MLTX logo

MLTX EBIT

annual EBIT:

-$143.09M-$88.97M(-164.38%)
December 31, 2024

Summary

  • As of today (June 17, 2025), MLTX annual earnings before interest & taxes is -$143.09 million, with the most recent change of -$88.97 million (-164.38%) on December 31, 2024.
  • MLTX annual EBIT is now -164.38% below its all-time high of -$54.12 million, reached on December 31, 2023.

Performance

MLTX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXincome statement metrics

quarterly EBIT:

-$40.39M+$9.19M(+18.54%)
March 31, 2025

Summary

  • As of today (June 17, 2025), MLTX quarterly earnings before interest & taxes is -$40.39 million, with the most recent change of +$9.19 million (+18.54%) on March 31, 2025.
  • Over the past year, MLTX quarterly EBIT has dropped by -$26.48 million (-190.46%).
  • MLTX quarterly EBIT is now -544.43% below its all-time high of -$6.27 million, reached on September 30, 2021.

Performance

MLTX quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXincome statement metrics

TTM EBIT:

-$163.66M-$26.48M(-19.31%)
March 31, 2025

Summary

  • As of today (June 17, 2025), MLTX TTM earnings before interest & taxes is -$163.66 million, with the most recent change of -$26.48 million (-19.31%) on March 31, 2025.
  • Over the past year, MLTX TTM EBIT has dropped by -$108.56 million (-197.04%).
  • MLTX TTM EBIT is now -400.76% below its all-time high of -$32.68 million, reached on June 30, 2021.

Performance

MLTX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

MLTX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-164.4%-190.5%-197.0%
3 y3 years--153.3%-198.2%
5 y5 years--23.6%-400.8%

MLTX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-164.4%at low-212.3%+18.5%-310.6%at low
5 y5-year-164.4%at low-544.4%+18.5%-400.8%at low
alltimeall time-164.4%at low-544.4%+18.5%-400.8%at low

MLTX EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$40.39M(-18.5%)
-$163.66M(+19.3%)
Dec 2024
-$143.09M(+164.4%)
-$49.58M(+15.0%)
-$137.18M(+33.7%)
Sep 2024
-
-$43.11M(+41.0%)
-$102.62M(+41.6%)
Jun 2024
-
-$30.58M(+119.9%)
-$72.49M(+31.6%)
Mar 2024
-
-$13.90M(-7.5%)
-$55.10M(+1.8%)
Dec 2023
-$54.12M
-$15.03M(+15.8%)
-$54.12M(-3.0%)
Sep 2023
-
-$12.98M(-1.6%)
-$55.79M(-3.1%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$13.19M(+2.0%)
-$57.58M(-7.2%)
Mar 2023
-
-$12.93M(-22.5%)
-$62.05M(-4.6%)
Dec 2022
-$65.06M
-$16.70M(+13.0%)
-$65.06M(+34.5%)
Sep 2022
-
-$14.77M(-16.3%)
-$48.37M(+21.3%)
Jun 2022
-
-$17.65M(+10.7%)
-$39.86M(-27.4%)
Mar 2022
-
-$15.94M(+154.4%)
-$54.89M(+40.9%)
Sep 2021
-
-$6.27M(-80.8%)
-$38.95M(+19.2%)
Jun 2021
-
-$32.68M
-$32.68M

FAQ

  • What is MoonLake Immunotherapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics annual EBIT year-on-year change?
  • What is MoonLake Immunotherapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics quarterly EBIT year-on-year change?
  • What is MoonLake Immunotherapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics TTM EBIT year-on-year change?

What is MoonLake Immunotherapeutics annual earnings before interest & taxes?

The current annual EBIT of MLTX is -$143.09M

What is the all time high annual EBIT for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high annual earnings before interest & taxes is -$54.12M

What is MoonLake Immunotherapeutics annual EBIT year-on-year change?

Over the past year, MLTX annual earnings before interest & taxes has changed by -$88.97M (-164.38%)

What is MoonLake Immunotherapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of MLTX is -$40.39M

What is the all time high quarterly EBIT for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high quarterly earnings before interest & taxes is -$6.27M

What is MoonLake Immunotherapeutics quarterly EBIT year-on-year change?

Over the past year, MLTX quarterly earnings before interest & taxes has changed by -$26.48M (-190.46%)

What is MoonLake Immunotherapeutics TTM earnings before interest & taxes?

The current TTM EBIT of MLTX is -$163.66M

What is the all time high TTM EBIT for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high TTM earnings before interest & taxes is -$32.68M

What is MoonLake Immunotherapeutics TTM EBIT year-on-year change?

Over the past year, MLTX TTM earnings before interest & taxes has changed by -$108.56M (-197.04%)
On this page